Targeted therapy and radiotherapy without chemotherapy

Options
docnov9
docnov9 Member Posts: 2
edited June 2015 in Just Diagnosed

What are the chances of recurrence of IDC in a 50-year old after BCS for Stage 2A, ER- & PR-, HER2 +3 with this regimen as adjuvant therapy? She is permanently partially disabled (numbness of her upper extremities, worst in her left hand and from her waist down to her lower extremities, worst in her right foot) from a cord compression (C5-C6, T9-T10), status post-surgery in 2013.

· Share on FacebookShare on Twitter

Comments

  • ElaineTherese
    ElaineTherese Member Posts: 3,328
    edited June 2015

    Gosh, I don't know the "chances." Will she be getting Herceptin alone? Or, Herceptin and Perjeta? Is chemo out of the question due to her disabilities? I would think that Herceptin and/or Perjeta would help, at the very least.

    · Share on FacebookShare on Twitter
  • docnov9
    docnov9 Member Posts: 2
    edited June 2015

    Just want to know the benefits of targeted and radiotherapy only (without chemo) in IDC Stage 2A, S/P BCS, right; Tumor size 2.3cm; Vascular invasion (+), 8 axillary nodes (-); ER & PR (-), HER2 (+3)

    · Share on FacebookShare on Twitter
  • debiann
    debiann Member Posts: 1,200
    edited June 2015

    herceptin

    Here's a link referring to this topic. While herceptin is approved for use alone, most early stagers get it in combination with chemo so I don't know the statistics for how effective it may be exist.

    However, there are many stage IV keeping cancer at bay for years on herceptin without chemo, so I think this suggests it can be pretty effective.

    · Share on FacebookShare on Twitter

Categories